Empagliflozin and Left Ventricular Remodeling in People Without Diabetes: Primary Results of the EMPA-HEART 2 CardioLink-7 Randomized Clinical Trial
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.